JP Morgan Chase
VERA icon

JP Morgan Chase’s Vera Therapeutics VERA Stock Holding History

JP Morgan Chase’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3M Sell
50,780
-12,335
-20% -$460K ﹤0.01% 4093
2026
Q1 		$2.4M Sell
63,115
-992
-2% -$42.7K ﹤0.01% 3969
2025
Q4 		$3.25M Sell
64,107
-18,258
-22% -$648K ﹤0.01% 3701
2025
Q3 		$2.39M Sell
82,365
-228,182
-73% -$5.28M ﹤0.01% 3944
2025
Q2 		$7.32M Buy
310,547
+262,805
+550% +$5.91M ﹤0.01% 2818
2025
Q1 		$1.15M Sell
47,742
-173,743
-78% -$5.58M ﹤0.01% 4250
2024
Q4 		$9.37M Buy
221,485
+92,390
+72% +$4.09M ﹤0.01% 2752
2024
Q3 		$5.71M Sell
129,095
-4,679
-3% -$178K ﹤0.01% 3125
2024
Q2 		$4.84M Sell
133,774
-201,790
-60% -$8M ﹤0.01% 3059
2024
Q1 		$14.5M Buy
335,564
+304,219
+971% +$10.8M ﹤0.01% 2160
2023
Q4 		$482K Buy
31,345
+8,284
+36% +$105K ﹤0.01% 4822
2023
Q3 		$316K Sell
23,061
-3,170
-12% -$54.4K ﹤0.01% 4754
2023
Q2 		$421K Buy
26,231
+9,589
+58% +$86.6K ﹤0.01% 4593
2023
Q1 		$129K Sell
16,642
-97,340
-85% -$751K ﹤0.01% 5315
2022
Q4 		$2.21M Buy
113,982
+38,652
+51% +$700K ﹤0.01% 3482
2022
Q3 		$1.6M Sell
75,330
-23,606
-24% -$442K ﹤0.01% 3653
2022
Q2 		$1.35M Sell
98,936
-50,665
-34% -$884K ﹤0.01% 3863
2022
Q1 		$3.51M Buy
149,601
+73,475
+97% +$1.58M ﹤0.01% 3300
2021
Q4 		$2.04M Sell
76,126
-2,526
-3% -$55.9K ﹤0.01% 3847
2021
Q3 		$1.36M Buy
+78,652
New +$1.41M ﹤0.01% 4076

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase's VERA Position: Q2 2026 in Review

JP Morgan Chase reduced its Vera Therapeutics (VERA) stake by 20% in Q2 2026, selling an estimated $460K and leaving 50,780 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #4093.

JP Morgan Chase first reported a position in VERA in Q3 2021 and has held it in 20 quarters since. The position peaked at $14.5M in Q1 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • JP Morgan Chase held 50,780 shares of Vera Therapeutics worth $2.3M as of Q2 2026.
  • JP Morgan Chase sold 12,335 Vera Therapeutics shares in Q2 2026, an estimated $460K.
  • Vera Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4093 holding.
  • JP Morgan Chase first reported a position in Vera Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's Vera Therapeutics position peaked at $14.5M in Q1 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.